Drug Discovery & Trials

Targets, biomarkers, AI discovery, and Phases I–III clinical results.

  • 19 Tracked terms
  • Last 30 days Feed window

What this topic collects on

An article joins this feed when it matches these terms. Each one is also a search of its own.

Latest in Drug Discovery & Trials


biopharminternational.com > view > novo-nordisk-partners-with-openai-for-drug-discovery

Novo Nordisk Partners with OpenAI for Drug Discovery

54+ min ago   (282+ words) Novo Nordisk intends to apply advanced AI to analyze complex data, improve target identification, and accelerate development of therapies for chronic diseases The deal comes at a time in which AI is rapidly reshaping how biopharma companies discover, develop, and…...


synbiobeta.com > read > synthetic-biology-in-the-open

Synthetic Biology in the Open

6+ hour, 54+ min ago   (571+ words) Researchers are sharing open source equipment designs, protocols, and code, but what is the synthetic biology community building with them? Synthetic biology is rooted in the idea that engineering principles of standardization, modularity, and abstraction can be applied to biology....


nature.com > articles > s41587-026-03338-3

Expanding global access to synthetic biology

17+ hour, 41+ min ago   (291+ words) Hanson, A. D. & de Lorenzo, V. ACS Synth. Biol. 12, 1579–1582 (2023). Holland, I. & Davies, J. A. Front. Bioeng. Biotechnol. 8, 571777 (2020). Wang, F. & Zhang, W. J. Biosaf. Biosecur. 1, 22–30 (2019). Cizauskas, C., DeBenedictis, E. & Kelly, P. New Biotechnol. 88, 1–11 (2025). Yang, N., Zhang, H., Han, X., Liu, Z. & Lu, Y. Front....


biobuzz.io > news > in-the-field-where-life-sciences-toughest-challenges-get-solved

In the field: Where life sciences’ toughest challenges get solved

8+ hour, 54+ min ago   (1168+ words) The usual story of life sciences innovation runs in a straight line: a target is identified, a molecule is designed, a process is developed, scaled and validated, and a therapy reaches patients. What that version leaves out is everything that…...


bioxconomy.com > modalities > rethinking-expression-to-accelerate-antibody-discovery

Rethinking Expression to Accelerate Antibody Discovery

4+ hour, 51+ min ago   (83+ words) This webinar will explore integrating the Pfenex Expression Technology® platform directly into the antibody screening workflow. Date: Oct 22, 2026 Time: 11:00 am EDT Complete activation to reserve your place. In this webinar, scientist Russell Coleman, who is director of strain engineering for…...


bioxconomy.com > modalities > dual-targeting-sirnas-could-treat-complex-genetic-diseases

Dual-targeting siRNAs could treat more complex genetic diseases

3+ hour, 36+ min ago   (1072+ words) An innovative bispecific siRNA design hits two genes at once, taking away one of cancer’s tricks for evading treatment. Some might say genetics research is in a rut. Biologists have made incredible biological and therapeutic discoveries over the past several…...


biotecnika.org > 2026 > 10 > biotecnika-times-12-10-2026

BioTecNika Times-12-10-2026: Paid Biotech Internship at FSL, IASST Internship & Project Dissertation, Freshers Jobs at USV & More

5+ hour, 10+ min ago   (58+ words) BioTecNika LEAVE A REPLY Cancel reply Save my name, email, and website in this browser for the next time I comment. Explore the BioTecNika Network Building successful careers across biotechnology, life sciences, chemistry, pharmaceuticals and healthcare. BioTecNika — Empowering scientific careers…...